Abrahao R, Brunson AM, Kahn JM, Li QW, et al. Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors. Leuk Lymphoma 2022 Jan 6:1-11. doi: 10.1080/10428194.2021.2020775.
PMID: 34989283